[Experience of therapy with axi-cel CAR-T in an elderly patient suffering from double expressor DLBCL in an advanced stage and refractory to first-line chemoimmunotherapy.].

• Tác giả: Maria Goldaniga
• Ngôn ngữ: eng
• Ký hiệu phân loại: 001.43 Historical, descriptive, experimental methods
• Thông tin xuất bản: Italy : Recenti progressi in medicina , 2025
• Bộ sưu tập: NCBI
• ID: 52179

Tóm tắt

We hereby describe a case of successful therapy with axicabtagene ciloleucel (axi-cel) chimeric antigen receptor T-cells (CAR-T) in an elderly patient suffering from DLBCL refractory to first-line chemoimmunotherapy, with particular reference to the setting of the diagnostic/therapeutic path and collaboration between the Referral center and the CAR-T center.